XML 192 R123.htm IDEA: XBRL DOCUMENT
v3.23.1

Non-current financial debt (Details 1) € in Millions, SFr in Millions, $ in Millions | 12 Months Ended |  |  |
--- | --- | --- | --- | ---
Dec. 31, 2022 USD ($) | Dec. 31, 2022 EUR (€) | Dec. 31, 2022 CHF (SFr) | Dec. 31, 2021 USD ($) | Dec. 31, 2020
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Straight bonds | $ 22,341 |  |  | $ 25,296 |
2.4% USD 1 500 million bond 2012/2022 of Novartis Capital Corporation, New York United States, issued at 99.225% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 2.40% | 2.40% | 2.40% |  |
Borrowings, original currency | USD |  |  |  |
Notional amount | $ 1,500 |  |  |  |
Borrowings, issuance year | 2012 |  |  |  |
Borrowings, maturity year | 2022 |  |  |  |
Borrowings, issuer | Novartis Capital Corporation, New York, United States |  |  |  |
Borrowings, issue price | 99.225% |  |  |  |
Straight bonds |  |  |  | 1,498 |
3.7% USD 500 million bond 2012/2042 of Novartis Capital Corporation, New York United States, issued at 98.325% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 3.70% | 3.70% | 3.70% |  |
Borrowings, original currency | USD |  |  |  |
Notional amount | $ 500 |  |  |  |
Borrowings, issuance year | 2012 |  |  |  |
Borrowings, maturity year | 2042 |  |  |  |
Borrowings, issuer | Novartis Capital Corporation, New York, United States |  |  |  |
Borrowings, issue price | 98.325% |  |  |  |
Straight bonds | $ 490 |  |  | 490 |
3.4% USD 2 150 million bond 2014/2024 of Novartis Capital Corporation, New York United States, issued at 99.287% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 3.40% | 3.40% | 3.40% |  |
Borrowings, original currency | USD |  |  |  |
Notional amount | $ 2,150 |  |  |  |
Borrowings, issuance year | 2014 |  |  |  |
Borrowings, maturity year | 2024 |  |  |  |
Borrowings, issuer | Novartis Capital Corporation, New York, United States |  |  |  |
Borrowings, issue price | 99.287% |  |  |  |
Straight bonds | $ 2,147 |  |  | 2,144 |
4.4% USD 1 850 million bond 2014/2044 of Novartis Capital Corporation, New York United States, issued at 99.196% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 4.40% | 4.40% | 4.40% |  |
Borrowings, original currency | USD |  |  |  |
Notional amount | $ 1,850 |  |  |  |
Borrowings, issuance year | 2014 |  |  |  |
Borrowings, maturity year | 2044 |  |  |  |
Borrowings, issuer | Novartis Capital Corporation, New York, United States |  |  |  |
Borrowings, issue price | 99.196% |  |  |  |
Straight bonds | $ 1,827 |  |  | 1,826 |
1.625% EUR 600 million bond 2014/2026 of Novartis Finance S.A. Luxembourg, Luxembourg, issued at 99.697% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 1.625% | 1.625% | 1.625% |  |
Borrowings, original currency | EUR |  |  |  |
Notional amount | € |  | € 600 |  |  |
Borrowings, issuance year | 2014 |  |  |  |
Borrowings, maturity year | 2026 |  |  |  |
Borrowings, issuer | Novartis Finance S.A., Luxembourg, Luxembourg |  |  |  |
Borrowings, issue price | 99.697% |  |  |  |
Straight bonds | $ 638 |  |  | 676 |
0.25% CHF 500 million bond 2015/2025 of Novartis AG Basel Switzerland, issued at 100.64% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 0.25% | 0.25% | 0.25% |  |
Borrowings, original currency | CHF |  |  |  |
Notional amount | SFr |  |  | SFr 500 |  |
Borrowings, issuance year | 2015 |  |  |  |
Borrowings, maturity year | 2025 |  |  |  |
Borrowings, issuer | Novartis AG, Basel, Switzerland |  |  |  |
Borrowings, issue price | 100.64% |  |  |  |
Straight bonds | $ 541 |  |  | 547 |
0.625% CHF 550 million bond 2015/2029 of Novartis AG Basel Switzerland, issued at 100.502% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 0.625% | 0.625% | 0.625% |  |
Borrowings, original currency | CHF |  |  |  |
Notional amount | SFr |  |  | SFr 550 |  |
Borrowings, issuance year | 2015 |  |  |  |
Borrowings, maturity year | 2029 |  |  |  |
Borrowings, issuer | Novartis AG, Basel, Switzerland |  |  |  |
Borrowings, issue price | 100.502% |  |  |  |
Straight bonds | $ 595 |  |  | 602 |
1.050% CHF 325 million bond 2015/2035 of Novartis AG Basel Switzerland, issued at 100.479% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 1.05% | 1.05% | 1.05% |  |
Borrowings, original currency | CHF |  |  |  |
Notional amount | SFr |  |  | SFr 325 |  |
Borrowings, issuance year | 2015 |  |  |  |
Borrowings, maturity year | 2035 |  |  |  |
Borrowings, issuer | Novartis AG, Basel, Switzerland |  |  |  |
Borrowings, issue price | 100.479% |  |  |  |
Straight bonds | $ 352 |  |  | 356 |
3.0% USD 1 750 million bond 2015/2025 of Novartis Capital Corporation, New York United States, issued at 99.010% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 3.00% | 3.00% | 3.00% |  |
Borrowings, original currency | USD |  |  |  |
Notional amount | $ 1,750 |  |  |  |
Borrowings, issuance year | 2015 |  |  |  |
Borrowings, maturity year | 2025 |  |  |  |
Borrowings, issuer | Novartis Capital Corporation, New York, United States |  |  |  |
Borrowings, issue price | 99.01% |  |  |  |
Straight bonds | $ 1,742 |  |  | 1,740 |
4.0% USD 1 250 million bond 2015/2045 of Novartis Capital Corporation, New York United States, issued at 98.029% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 4.00% | 4.00% | 4.00% |  |
Borrowings, original currency | USD |  |  |  |
Notional amount | $ 1,250 |  |  |  |
Borrowings, issuance year | 2015 |  |  |  |
Borrowings, maturity year | 2045 |  |  |  |
Borrowings, issuer | Novartis Capital Corporation, New York, United States |  |  |  |
Borrowings, issue price | 98.029% |  |  |  |
Straight bonds | $ 1,221 |  |  | 1,220 |
0.125% EUR 1 250 million bond 2016/2023 of Novartis Finance S.A. Luxembourg, Luxembourg, issued at 99.127% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 0.125% | 0.125% | 0.125% |  |
Borrowings, original currency | EUR |  |  |  |
Notional amount | € |  | € 1,250 |  |  |
Borrowings, issuance year | 2016 |  |  |  |
Borrowings, maturity year | 2023 |  |  |  |
Borrowings, issuer | Novartis Finance S.A., Luxembourg, Luxembourg |  |  |  |
Borrowings, issue price | 99.127% |  |  |  |
Straight bonds | $ 1,330 |  |  | 1,409 |
0.625% EUR 500 million bond 2016/2028 of Novartis Finance S.A. Luxembourg, Luxembourg, issued at 98.48% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 0.625% | 0.625% | 0.625% |  |
Borrowings, original currency | EUR |  |  |  |
Notional amount | € |  | € 500 |  |  |
Borrowings, issuance year | 2016 |  |  |  |
Borrowings, maturity year | 2028 |  |  |  |
Borrowings, issuer | Novartis Finance S.A., Luxembourg, Luxembourg |  |  |  |
Borrowings, issue price | 98.48% |  |  |  |
Straight bonds | $ 528 |  |  | 559 |
2.400% USD 1'000 million 2017/2022 of Novartis Capital Corporation, New York, United States, issued at 99.449% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 2.40% | 2.40% | 2.40% |  |
Borrowings, original currency | USD |  |  |  |
Notional amount | $ 1,000 |  |  |  |
Borrowings, issuance year | 2017 |  |  |  |
Borrowings, maturity year | 2022 |  |  |  |
Borrowings, issuer | Novartis Capital Corporation, New York, United States |  |  |  |
Borrowings, issue price | 99.449% |  |  |  |
Straight bonds |  |  |  | 1,000 |
3.100% USD 1'000 million 2017/2027 of Novartis Capital Corporation, New York, United States, issued at 99.109% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 3.10% | 3.10% | 3.10% |  |
Borrowings, original currency | USD |  |  |  |
Notional amount | $ 1,000 |  |  |  |
Borrowings, issuance year | 2017 |  |  |  |
Borrowings, maturity year | 2027 |  |  |  |
Borrowings, issuer | Novartis Capital Corporation, New York, United States |  |  |  |
Borrowings, issue price | 99.109% |  |  |  |
Straight bonds | $ 994 |  |  | 993 |
1.125% EUR 600 million 2017/2027 of Novartis Finance S.A., Luxembourg, Luxembourg, issued at 99.874% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 1.125% | 1.125% | 1.125% |  |
Borrowings, original currency | EUR |  |  |  |
Notional amount | € |  | € 600 |  |  |
Borrowings, issuance year | 2017 |  |  |  |
Borrowings, maturity year | 2027 |  |  |  |
Borrowings, issuer | Novartis Finance S.A., Luxembourg, Luxembourg |  |  |  |
Borrowings, issue price | 99.874% |  |  |  |
Straight bonds | $ 638 |  |  | 677 |
0.500% EUR 750 million 2018/2023 of Novartis Finance S.A., Luxembourg, Luxembourg issued at 99.655% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 0.50% | 0.50% | 0.50% |  |
Borrowings, original currency | EUR |  |  |  |
Notional amount | € |  | € 750 |  |  |
Borrowings, issuance year | 2018 |  |  |  |
Borrowings, maturity year | 2023 |  |  |  |
Borrowings, issuer | Novartis Finance S.A., Luxembourg, Luxembourg |  |  |  |
Borrowings, issue price | 99.655% |  |  |  |
Straight bonds | $ 798 |  |  | 846 |
1.375% EUR 750 million 2018/2030 of Novartis Finance S.A., Luxembourg, Luxembourg issued at 99.957% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 1.375% | 1.375% | 1.375% |  |
Borrowings, original currency | EUR |  |  |  |
Notional amount | € |  | € 750 |  |  |
Borrowings, issuance year | 2018 |  |  |  |
Borrowings, maturity year | 2030 |  |  |  |
Borrowings, issuer | Novartis Finance S.A., Luxembourg, Luxembourg |  |  |  |
Borrowings, issue price | 99.957% |  |  |  |
Straight bonds | $ 797 |  |  | 846 |
1.700% EUR 750 million 2018/2038 of Novartis Finance S.A., Luxembourg, Luxembourg issued at 99.217% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 1.70% | 1.70% | 1.70% |  |
Borrowings, original currency | EUR |  |  |  |
Notional amount | € |  | € 750 |  |  |
Borrowings, issuance year | 2018 |  |  |  |
Borrowings, maturity year | 2038 |  |  |  |
Borrowings, issuer | Novartis Finance S.A., Luxembourg, Luxembourg |  |  |  |
Borrowings, issue price | 99.217% |  |  |  |
Straight bonds | $ 792 |  |  | 840 |
1.750% USD 1 000 million 2020/2025 Novartis Capital Corporation, New York, United States, issued at 99.852% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 1.75% | 1.75% | 1.75% |  |
Borrowings, original currency | USD |  |  |  |
Notional amount | $ 1,000 |  |  |  |
Borrowings, issuance year | 2020 |  |  |  |
Borrowings, maturity year | 2025 |  |  |  |
Borrowings, issuer | Novartis Capital Corporation, New York, United States |  |  |  |
Borrowings, issue price | 99.852% |  |  |  |
Straight bonds | $ 998 |  |  | 998 |
2.000% USD 1 250 million 2020/2027 Novartis Capital Corporation, New York, United States, issued at 99.909% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 2.00% | 2.00% | 2.00% |  |
Borrowings, original currency | USD |  |  |  |
Notional amount | $ 1,250 |  |  |  |
Borrowings, issuance year | 2020 |  |  |  |
Borrowings, maturity year | 2027 |  |  |  |
Borrowings, issuer | Novartis Capital Corporation, New York, United States |  |  |  |
Borrowings, issue price | 99.909% |  |  |  |
Straight bonds | $ 1,246 |  |  | 1,246 |
2.200% USD 1 500 million 2020/2030 Novartis Capital Corporation, New York, United States, issued at 99.869% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 2.20% | 2.20% | 2.20% |  |
Borrowings, original currency | USD |  |  |  |
Notional amount | $ 1,500 |  |  |  |
Borrowings, issuance year | 2020 |  |  |  |
Borrowings, maturity year | 2030 |  |  |  |
Borrowings, issuer | Novartis Capital Corporation, New York, United States |  |  |  |
Borrowings, issue price | 99.869% |  |  |  |
Straight bonds | $ 1,494 |  |  | 1,493 |
2.750% USD 1 250 million 2020/2050 Novartis Capital Corporation, New York, United States, issued at 97.712% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 2.75% | 2.75% | 2.75% |  |
Borrowings, original currency | USD |  |  |  |
Notional amount | $ 1,250 |  |  |  |
Borrowings, issuance year | 2020 |  |  |  |
Borrowings, maturity year | 2050 |  |  |  |
Borrowings, issuer | Novartis Capital Corporation, New York, United States |  |  |  |
Borrowings, issue price | 97.712% |  |  |  |
Straight bonds | $ 1,215 |  |  | 1,214 |
0.000% 1 EUR 1 850 million 2020/2028 Novartis Finance S.A., Luxembourg, Luxembourg, issued at 99.354% [member] |  |  |  |  |
Disclosure of detailed information about borrowings [line items] |  |  |  |  |
Borrowings, coupon | 0.00% | 0.00% | 0.00% |  |
Borrowings, original currency | EUR |  |  |  |
Notional amount | € |  | € 1,850 |  |  |
Borrowings, issuance year | 2020 |  |  |  |
Borrowings, maturity year | 2028 |  |  |  |
Borrowings, issuer | Novartis Finance S.A., Luxembourg, Luxembourg |  |  |  |
Borrowings, issue price | 99.354% |  |  |  |
Straight bonds | $ 1,958 |  |  | $ 2,076 |
Borrowings interest rate step up |  |  |  |  | 25.00%

X
- Definition The amount of bonds issued by the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2022-03-24 -Paragraph 112 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_112_c&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_BondsIssued
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The interest rate on borrowings. [Refer: Borrowings] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 7 -IssueDate 2022-03-24 -Paragraph 7 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_BorrowingsInterestRate
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The maturity of borrowings. [Refer: Borrowings] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 7 -IssueDate 2022-03-24 -Paragraph 7 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_BorrowingsMaturity
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The currency in which the borrowings are denominated. [Refer: Borrowings] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 7 -IssueDate 2022-03-24 -Paragraph 7 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_BorrowingsOriginalCurrency
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The nominal or face amount of a financial instrument, used to calculate payments made on that instrument. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2022-03-24 -Paragraph 112 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_112_c&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_NotionalAmount
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | nvs_BorrowingsInterestRateStepUp
Namespace Prefix: | nvs_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | nvs_BorrowingsIssuanceDate
Namespace Prefix: | nvs_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_BorrowingsLender
Namespace Prefix: | nvs_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_BorrowingsPremiumDiscount
Namespace Prefix: | nvs_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A1.750USD1000Million20202025NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.852Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A2.000USD1250Million20202027NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.909Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A2.200USD1500Million20202030NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.869Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A2.750USD1250Million20202050NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt97.712Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BorrowingsByNameAxis=nvs_A0.0001EUR1850Million20202028NovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.354Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |